SAX 187

Drug Profile

SAX 187

Alternative Names: SAX-187; WAY-181187

Latest Information Update: 17 Jan 2008

Price : $50

At a glance

  • Originator Wyeth
  • Class Anxiolytics; Imidazoles; Indoles
  • Mechanism of Action Serotonin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders

Most Recent Events

  • 19 Sep 2005 Data presented at the 230th American Chemical Society National Meeting - (230th-ACS-2005) have been added to the Anxiety disorders pharmacodynamics section
  • 29 Jul 2004 Phase-I clinical trials in Anxiety disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top